Availability of insulin pump therapy in clinical practice

Diabetic Medicine

Volumn 29, Issue 8, 2012, Pages 1055-1059

  Carlsson, B M ^a   Andersson, P Nord ^b   Alnervik, J ^b   Carstensen, J ^b   Lind, M ^c,d  

^a Diabetes Section of Medicine   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d NU Hospital Organization   (Sweden)

Author keywords

Age; Availability; Continuous subcutaneous insulin infusion; Sex

Indexed keywords

CREATININE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT;

ADULT; AMBULATORY CARE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; ODDS RATIO; SWEDEN; YOUNG ADULT;

EID: 84864010086     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03517.x     Document Type: Article

References (14)

1. DCCT Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ et al. Intensive diabetes treatment and cardiovascular disease in patients with type1 diabetes. N Engl J Med 2005; 353: 2643-2653.
3. Pickup JC, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type1 and type2 diabetes. Diabetes Care 2008; 31: S140-S145.
4. Hanaire H, Lassmann-Vague V, Jeandidier N, Renard E, Tubiana-Rufi N, Vambergue A et al. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 2008; 34: 401-423.
5. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type1 diabetes mellitus. Cochrane Database Syst Rev 2010; 1: CD005103.
6. Monami M, Lamanna C, Marchionni N, Mannucci E. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type1 diabetes: a meta-analysis. Acta Diabetol 2010; 47: 77-81.
7. Fahlén M, Eliasson B, Odén A. Optimization of basal insulin delivery in Type1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine. Diabet Med 2005; 22: 382-386.
8. National Board of Health and Welfare. Nationella Riktlinjer för diabetesvården (National Guidelines for Diabetes Care). 2010. Available at Last accessed 1 July 2010.
9. Journalia. Available at Last accessed 1 July 2010.
10. Lind M, Fahlén M, Happich M, Odén A, Eliasson B. The effect of insulin lispro on glycemic control in a large patient cohort. Diabetes Technol Ther 2009; 11: 51-56.
11. 1c variables. PLoS One 2009; 4: e4412.
12. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004; 50: 166-174.
13. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-983.
14. Courtenay WH. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med 2000; 50: 1385-1401.